1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cholangitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kambayashi, J; Kawasaki, T; Mori, T; Ou, MC; Sakon, M; Shiba, E; Shinozaki, K; Uemura, Y; Yukawa, M | 1 |
Higure, A; Itoh, H; Katoh, H; Nagafuchi, Y; Nakamura, S; Ohsato, K; Okamoto, K; Okazaki, K; Takeda, S; Todoroki, H | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cholangitis
Article | Year |
---|---|
Potential etiologic role of PAF in two major septic complications; disseminated intravascular coagulation and multiple organ failure.
Topics: Alanine Transaminase; Animals; Bacterial Infections; Blood Cell Count; Blood Urea Nitrogen; Cholangitis; Common Bile Duct; Disseminated Intravascular Coagulation; Endotoxins; Fibrinogen; Hematocrit; Liver; Male; Multiple Organ Failure; Partial Thromboplastin Time; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Rabbits | 1994 |
Possible role of platelet-activating factor in the in vivo expression of tissue factor in neutrophils.
Topics: Animals; Aspartate Aminotransferases; Blood Coagulation; Cholangitis; Disease Models, Animal; Leukocytes; Liver; Male; Neutrophils; Platelet Activating Factor; Rabbits; Thiazoles; Thiazolidines; Thromboplastin | 1998 |